Cardiac amyloidosis a case report

Authors

DOI:

https://doi.org/10.33448/rsd-v9i3.2412

Keywords:

Amyloidosis; Cardiomyopathy; Hypertrophic; Restrictive; Heart Failure.

Abstract

The authors presented a case of amyloidosis with cardiac involvement in an elderly woman, with a previous history of arterial hypertension, permanent atrial fibrillation and acute heart failure of unknown etiology. The authors presented a case of amyloidosis with cardiac involvement in an elderly woman, with a previous history of arterial hypertension, permanent atrial fibrillation and acute heart failure of unknown etiology. Amyloidosis is a rare and heterogeneous group of diseases, characterized by the extracellular deposit of amyloid protein. There are several types of proteins identified. The most common are tranterritin (TTR) and light chain immunoglobulin (AL), amyloidosis AL, produced in excess by immune cells. Amyloid accumulation can be found anywhere in the body; such as the tongue, heart, adipose tissue, kidney among others. When no underlying disease (secondary amyloidosis) is identified, the term primary or systemic is used. In the latter, the involvement of the heart, with infiltration of the extracellular space by glycoproteins, is very frequent. This work aims to demonstrate the importance of the differential diagnosis of infiltrative cardiomyopathies, in amyloidosis with involvement in other sites such as tongue and cardiac manifestations of the disease, with the diagnosis of transthoracic echocardiography and tongue biopsy diagnosed in a patient at the Cardiology Service of  the Army's Central Hospital- Rio de Janeiro – RJ.

References

Alambert, C. O., Sarpi, M. O., Dedivitis, R. A., Alambert, P. A., Sementilli, Â., & Arantes, L. P. (2007). Macroglossia como primeira manifestação clínica da amiloidose primária. Revista Brasileira de Reumatologia, 47(1), 76-79. Recuperado em 12 fevereiro, 2020, de https://dx.doi.org/10.1590/S0482-50042007000100016

Dubrey, S. W., Cha, K., Skinner, M., LaValley, M., & Falk, R. H. (1997). Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart (British Cardiac Society), 78(1), 74–82. Recuperado em 12 fevereiro, 2020, de https://doi.org/10.1136/hrt.78.1.74

Falk, R. H. (2011). Cardiac amyloidosis: a treatable disease, often overlooked. Circulation, 124(9), 1079–1085. Recuperado em 12 fevereiro, 2020, de https://doi.org/10.1161/CIRCULATIONAHA.110.010447

Fernandes, A., Caetano, F., Almeida, I., Paiva, L., Gomes, P., Mota, P., & Leitão Marques, A. (2016). Amiloidose cardíaca – abordagem diagnóstica, a propósito de um caso clínico. Revista Portuguesa de Cardiologia, 35(5), 305.e1-305.e7. Recuperado em 08 dezembro, 2019, de https://doi.org/10.1016/j.repc.2016.01.004

Gertz, M. A. (2011). Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management. American Journal of Hematology, 86(2), 180–186. Recuperado em 12 fevereiro, 2020, de https://doi.org/10.1002/ajh.21934

Hassan, W., Al-Sergani, H., Mourad, W., & Tabbaa, R. (2005). Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management. Texas Heart Institute Journal, 32(2), 178–184.

Jorge, A. J. L., Ávila, D. X., Vilar, E. G. ;Ribeiro, M L., Bruno, K. E. H., & Pires, A. C. (2018). Cardiac Amyloidosis with Heart Failure and Middle Range Ejection Fraction. International Journal of Cardiovascular Sciences, 31(4), 457-460. Recuperado em 12 fevereiro, 2020, de https://doi.org/10.5935/2359-4802.20180039

Kristen, A. V., Dengler, T. J., Hegenbart, U., Schonland, S. O., Goldschmidt, H., Sack, F. U., Bauer, A. (2008). Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm, 5(2), 235–240. Recuperado em 12 fevereiro, 2020, de https://doi.org/10.1016/j.hrthm.2007.10.016

Mendes, R. G. G., Evora, P. R. B., Mendes, J. A. M., Haddad, J., & Carvalho, S. (1998). Comprometimento cardíaco na amiloidose sistêmica. Diagnóstico in vivo. Arquivos Brasileiros de Cardiologia, Vol. 70, pp. 119–123. Recuperado em 08 dezembro, 2019, de https://doi.org/http://dx.doi.org/10.1590/S0066-782X1998000200010

Mesquita, E. T., Jorge, A. J. L., Souza, C. V., Jr, & Andrade, T. R. (2017). Amiloidose Cardíaca e seu Novo Fenótipo Clínico: Insuficiência Cardíaca com Fração de Ejeção Preservada. Arquivos Brasileiros de Cardiologia, 109(1), 71-80. Recuperado em 12 fevereiro, 2020, de Epub June 29, 2017.https://dx.doi.org/10.5935/abc.20170079

Murtagh, B., Hammill, S. C., Gertz, M. A., Kyle, R. A., Tajik, A. J., & Grogan, M. (2005) Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement The American Journal of Cardiology, 95(4), 535–537. Recuperado em 12 fevereiro, 2020, de https://doi.org/10.1016/J.AMJCARD.2004.10.028

Ng, B., Connors, L. H., Davidoff, R., Skinner, M., & Falk, R. H. (2005). Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Archives of Internal Medicine, 165(12), 1425–1429. Recuperado em 12 fevereiro, 2020, de https://doi.org/10.1001/archinte.165.12.1425

Nohria, A. (2012). Should we avoid heart transplantation in cardiomyopathy due to radiotherapy/chemotherapy or amyloidosis? The devil is in the details. The Journal of Heart and Lung Transplantation, 31(12), 1253-1256. . Recuperado em 12 fevereiro, 2020, de https://doi.org/10.1016/j.healun.2012.10.014

Pollak, A., & Falk, R. H. (1993). Left Ventricular Systolic Dysfunction Precipitated by Verapamil in Cardiac Amyloidosis. Chest, 104(2), 618–620. Recuperado em 12 fevereiro, 2020, de https://doi.org/10.1378/CHEST.104.2.618

Quagliato, P. C., Neto, E. M. V. S., Assef, J. E., de Mattos Barretto, R. B., de Barros Correia, E., Neto, F. S., & Smanio, P. E. P. (2018). O Que Há de Novo na Amiloidose Cardíaca?. Arq Bras Cardiol: Imagem cardiovasc.;31(3):198-203, Recuperado em 12 fevereiro, 2020 de http://departamentos.cardiol.br/dic/publicacoes/revistadic/revista/2018/portugues/Revista03/revista-abc-imagem-revisao-3103-amilodoise-portugues.pdf

Rapezzi, C., Merlini, G., Quarta, C. C., Riva, L., Longhi, S., Leone, O., … Perlini, S. (2009). Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation, 120(13), 1203–1212. Recuperado em 12 fevereiro, 2020, de https://doi.org/10.1161/CIRCULATIONAHA.108.843334

Rubinow, A., Skinner, M., & Cohen, A. S. (1981). Digoxin sensitivity in amyloid cardiomyopathy. Circulation, 63(6), 1285–1288. Recuperado em 12 fevereiro, 2020, de https://doi.org/10.1161/01.cir.63.6.1285

Xavier, S. D., Bussoloti I. Filho, & Müller, H. (2004). Macroglossia decorrente deamiloidose sistêmica: relato de caso e revisão de literatura. Revista Brasileira de Otorrinolaringologia, Vol. 70, pp. 715–719. Recuperado em 08 dezembro, 2019 de https://doi.org/http://dx.doi.org/10.1590/S0034-72992004000500023.

Published

06/03/2020

How to Cite

DESTRO, C. R. de S.; SANTOS, A. V. dos; RANGEL, T. A. R.; DESTRO, C.; SILVA, R. M. C. R. A.; PEREIRA, E. R. Cardiac amyloidosis a case report. Research, Society and Development, [S. l.], v. 9, n. 3, p. e174932412, 2020. DOI: 10.33448/rsd-v9i3.2412. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/2412. Acesso em: 19 apr. 2024.

Issue

Section

Health Sciences